189 related articles for article (PubMed ID: 37684173)
1. Carbohydrates as putative pattern recognition receptor agonists in vaccine development.
Mu R; Dong L; Wang C
Trends Immunol; 2023 Oct; 44(10):845-857. PubMed ID: 37684173
[TBL] [Abstract][Full Text] [Related]
2. Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants.
Ong GH; Lian BSX; Kawasaki T; Kawai T
Front Cell Infect Microbiol; 2021; 11():745016. PubMed ID: 34692565
[TBL] [Abstract][Full Text] [Related]
3. Targeting Pattern Recognition Receptors (PRR) for Vaccine Adjuvantation: From Synthetic PRR Agonists to the Potential of Defective Interfering Particles of Viruses.
Vasou A; Sultanoglu N; Goodbourn S; Randall RE; Kostrikis LG
Viruses; 2017 Jul; 9(7):. PubMed ID: 28703784
[TBL] [Abstract][Full Text] [Related]
4. Trained Immunity-Based Vaccines: A New Paradigm for the Development of Broad-Spectrum Anti-infectious Formulations.
Sánchez-Ramón S; Conejero L; Netea MG; Sancho D; Palomares Ó; Subiza JL
Front Immunol; 2018; 9():2936. PubMed ID: 30619296
[TBL] [Abstract][Full Text] [Related]
5. Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses.
Tukhvatulin AI; Dzharullaeva AS; Tukhvatulina NM; Shcheblyakov DV; Shmarov MM; Dolzhikova IV; Stanhope-Baker P; Naroditsky BS; Gudkov AV; Logunov DY; Gintsburg AL
PLoS One; 2016; 11(5):e0155650. PubMed ID: 27187797
[TBL] [Abstract][Full Text] [Related]
6. Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants.
Olive C
Expert Rev Vaccines; 2012 Feb; 11(2):237-56. PubMed ID: 22309671
[TBL] [Abstract][Full Text] [Related]
7. Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants.
Maisonneuve C; Bertholet S; Philpott DJ; De Gregorio E
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12294-9. PubMed ID: 25136133
[TBL] [Abstract][Full Text] [Related]
8. Innate sensors that regulate vaccine responses.
Georg P; Sander LE
Curr Opin Immunol; 2019 Aug; 59():31-41. PubMed ID: 30978666
[TBL] [Abstract][Full Text] [Related]
9. Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants.
Miyaji EN; Carvalho E; Oliveira ML; Raw I; Ho PL
Braz J Med Biol Res; 2011 Jun; 44(6):500-13. PubMed ID: 21584443
[TBL] [Abstract][Full Text] [Related]
10. Immunological Mechanism and Clinical Application of PAMP Adjuvants.
Yan Y; Yao D; Li X
Recent Pat Anticancer Drug Discov; 2021; 16(1):30-43. PubMed ID: 33563182
[TBL] [Abstract][Full Text] [Related]
11. Synthetic Toll-like receptor agonists for the development of powerful malaria vaccines: a patent review.
Kaur A; Kannan D; Mehta SK; Singh S; Salunke DB
Expert Opin Ther Pat; 2018 Nov; 28(11):837-847. PubMed ID: 30280939
[TBL] [Abstract][Full Text] [Related]
12. Immunobiology of Carbohydrates: Implications for Novel Vaccine and Adjuvant Design Against Infectious Diseases.
Stefanetti G; Borriello F; Richichi B; Zanoni I; Lay L
Front Cell Infect Microbiol; 2021; 11():808005. PubMed ID: 35118012
[TBL] [Abstract][Full Text] [Related]
13. Rational Design of T-Cell- and B-Cell-Based Therapeutic Cancer Vaccines.
Li WH; Su JY; Li YM
Acc Chem Res; 2022 Sep; 55(18):2660-2671. PubMed ID: 36048514
[TBL] [Abstract][Full Text] [Related]
14. Glycovaccinology: The design and engineering of carbohydrate-based vaccine components.
Hulbert SW; Desai P; Jewett MC; DeLisa MP; Williams AJ
Biotechnol Adv; 2023 Nov; 68():108234. PubMed ID: 37558188
[TBL] [Abstract][Full Text] [Related]
15. Targeting Syk-Card9-activating C-type lectin receptors by vaccine adjuvants: findings, implications and open questions.
Lang R; Schoenen H; Desel C
Immunobiology; 2011 Nov; 216(11):1184-91. PubMed ID: 21742403
[TBL] [Abstract][Full Text] [Related]
16. Carbohydrate-based vaccine adjuvants - discovery and development.
Hu J; Qiu L; Wang X; Zou X; Lu M; Yin J
Expert Opin Drug Discov; 2015 Oct; 10(10):1133-44. PubMed ID: 26372693
[TBL] [Abstract][Full Text] [Related]
17. Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants.
Kumar S; Sunagar R; Gosselin E
Front Immunol; 2019; 10():1144. PubMed ID: 31191528
[TBL] [Abstract][Full Text] [Related]
18. Strategies to link innate and adaptive immunity when designing vaccine adjuvants.
Garlapati S; Facci M; Polewicz M; Strom S; Babiuk LA; Mutwiri G; Hancock RE; Elliott MR; Gerdts V
Vet Immunol Immunopathol; 2009 Mar; 128(1-3):184-91. PubMed ID: 19042032
[TBL] [Abstract][Full Text] [Related]
19. Blueprints of signaling interactions between pattern recognition receptors: implications for the design of vaccine adjuvants.
Timmermans K; Plantinga TS; Kox M; Vaneker M; Scheffer GJ; Adema GJ; Joosten LA; Netea MG
Clin Vaccine Immunol; 2013 Mar; 20(3):427-32. PubMed ID: 23345580
[TBL] [Abstract][Full Text] [Related]
20. Vaccine adjuvants: mechanisms and platforms.
Zhao T; Cai Y; Jiang Y; He X; Wei Y; Yu Y; Tian X
Signal Transduct Target Ther; 2023 Jul; 8(1):283. PubMed ID: 37468460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
